Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells

Author(s):
Geus, S.W.L. de; Baart, V.M.; Boonstra, M.C.; Kuppen, P.J.K.; Prevoo, H.A.J.M.; Mazar, A.P.; Bonsing, B.A.; Morreau, H.; Velde, C.J.H. van de; Vahrmeijer, A.L.; Sier, C.F.M. (0000-0002-4337-2758)
Published
2017
Publication type
Article / Letter to editor
Pancreatic adenocarcinomaimmunohistochemistrysurvivaluPARstroma
Date issued
2017-06-22
Language
English
Is part of
Biomarker Insights (2017), Vol. 12, p. 1-9
hdl
1887/114882
doi
10.1177/1177271917715443